CFCamilo Fernandez

Camilo Fernandez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Camilo Fernandez has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Metabolomic Markers of Left Ventricular Structure, Diastolic Function, and Risk of Coronary Heart Disease: A Longitudinal Study in American Indian Individuals

    by Mingjing Chen, Yixi Sun, Guanhong Miao, Xiaoxiao Wen, Alexander C. Razavi, Camilo Fernandez, Mary J. Roman, Richard B. Devereux, Richard R. Fabsitz, Ying Zhang, et al.

    Background: Subclinical alterations in left ventricular (LV) structure, diastolic function, and metabolic disturbances are associated with coronary heart disease (CHD) risk, but their relationships remained unclear. Large‐scale longitudinal metabolomic profiling of LV measures is lacking. Methods: Using untargeted metabolomics, we quantified 563 fasting plasma metabolites from 1799 American Indian individuals attending 2 exams (~5.5 years apart). We examined associations between metabolites and measures of LV structure (LV mass index, relative wall thickness), and diastolic function (peak early filling velocity to peak late filling velocity, isovolumic relaxation time, and deceleration time) using generalized estimating equation model. Findings were then replicated in an independent biracial cohort. Frailty Cox proportional hazards models were used to examine whether LV‐related metabolites are associated with the risk of CHD over a 20‐year follow‐up. Pathway enrichment analysis was performed to identify relevant metabolic pathways. Results: We identified 173 metabolites (47 named; q <0.05) associated with LV structure or diastolic function in the SHFS (Strong Heart Family Study), and some metabolites were confirmed in the biracial cohort. Three metabolites were additionally associated with incident CHD. Aspartic acid and palmitoleic acid were associated with lower LV mass index and peak early filling velocity to peak late filling velocity ratio and lower CHD risk (hazard ratios [HRs], 0.75 [95% CI, 0.56–0.99] to 0.81 [95% CI, 0.67–0.99]), whereas isothreonic acid was associated with higher relative wall thickness and higher CHD risk (HR, 1.15 [95% CI, 1.01–1.32]). LV‐related metabolites were enriched in arginine biosynthesis, alanine–aspartate–glutamate metabolism, and starch and sucrose metabolism. Conclusions: We identified metabolomic markers of LV structure and diastolic function, several of which that were independently associated with CHD risk, providing insight into metabolic pathways underlying LV subclinical changes and CHD.

  • Open Access

    The effect of birthweight and gestational age on cognitive function in midlife: the Bogalusa heart study

    by Eunsun Gill, David J. Libon, Soo Jung Kang, Ileana De Anda-Duran, Lydia A. Bazzano, Wei Chen, Camilo Fernandez-Alonso, Emily W. Harville

    Although the relationships between birthweight, gestational age (GA), and cognitive function (CF) before midlife have been demonstrated, the relationships after midlife and potential racial disparities remain inconclusive. This study examined the association between birthweight, GA, and midlife CF stratified by race. 1,032 subjects from the Bogalusa Heart Study (67% Whites, 33% Blacks, mean age 48.1 ± 5.3 years) were studied. Cognition was assessed with tests measuring verbal episodic memory, working memory, attention, graphomotor information processing speed, and global CF. Each test was standardized by sex and age, then averaged. The global CF was computed by averaging all cognitive test scores. Standardized scores from the Wide Range Achievement Test-IV (WRAT- IV)–Reading subtest and the Wechsler Adult Intelligence Scale- IV (WAIS-IV)–Vocabulary subtest measured achieved education. Multivariate linear regression was used to estimate the association. A 100-gram increase in birthweight was associated with an increase of 0.007 standardized units in global CF (SE: 0.003; p = 0.016), 0.007 in working memory (SE: 0.003; p = 0.041), and 0.012 in graphomotor processing speed (SE: 0.004; p = 0.010). Stratified by race, the associations between birthweight and global CF and CF subdomains were not statistically significant in either race, likely due to reduced power, as the estimates in both races showed similar effect sizes to those in the total sample. No differences were observed in CF subdomains among small for GA, appropriate for GA, and large for GA groups. GA, analyzed as a continuous variable, was not associated with CF. However, in preterm births, it was associated with better global CF, working memory, and graphomotor information processing speed, while there was no association in term-born births. The impact of birthweight on the global CF remained in middle age, while the impact of birthweight adjusted for GA did not. GA as a continuous variable was not associated with CF, except in preterm individuals, where it was associated with better CF. These results suggest that birthweight may influence CF in midlife, and GA may play a role, particularly in those born preterm.


  • Open Access

    Relationship Between Left Ventricular Hypertrophy and Diabetes Is Likely Bidirectional: A Temporality Analysis

    by Jiali Lv, Yang Liu, Yinkun Yan, Dianjianyi Sun, Lijun Fan, Yajun Guo, Camilo Fernandez, Lydia Bazzano, Jiang He, Shengxu Li, et al.

    Background: The temporal relationship between type 2 diabetes (T2DM) and left ventricular hypertrophy (LVH) is not well established. This study aims to examine the temporal sequence between T2DM and LVH/cardiac geometry patterns in middle‐aged adults. Methods and Results: The longitudinal cohort consisted of 1000 adults (682 White individuals and 318 Black individuals; 41.1% men; mean age, 36.2 years at baseline) who had data on fasting glucose/T2DM, left ventricular mass index (LVMI), and relative wall thickness collected twice at baseline and follow‐up over 9.4 years on average. The cross‐lagged path analysis model in 905 adults who did not take antidiabetic medications and the longitudinal prediction model in 1000 adults were used to examine the temporal relationships of glucose/T2DM with LVMI, LVH, relative wall thickness, and remodeling patterns. After adjustment for age, race, sex, smoking, alcohol drinking, body mass index, heart rate, hypertension, and follow‐up years, the path coefficient from baseline LVMI to follow‐up glucose was 0.088 ( P =0.005); the path from baseline glucose to follow‐up LVMI was −0.009 ( P =0.758). The 2 paths between glucose and relative wall thickness were not significant. The path analysis parameters did not differ significantly between race, sex, and follow‐up duration subgroups. Incidence of T2DM was higher in the baseline LVH group than in the normal LVMI group (24.8% versus 8.8%; P =0.017 for difference). Incidence of LVH and concentric LVH was higher in the baseline T2DM group than in the group without T2DM (50.0% versus 18.2% for LVH [ P =0.005 for difference]; 41.7% versus 12.6% for concentric LVH [ P =0.004 for difference]), with adjustment for covariates. Conclusions: This study suggests that the temporal relationship between T2DM and LVH is likely bidirectional. The path from LVMI/LVH to glucose/T2DM is stronger than the path from glucose/T2DM to LVMI/LVH.


  • Advances in Genomics Research of Blood Pressure Responses to Dietary Sodium and Potassium Intakes

    by Michael A. Razavi, Lydia A. Bazzano, Jovia Nierenberg, Zhijie Huang, Camilo Fernandez, Alexander C. Razavi, Seamus P. Whelton, Jiang He, Tanika N. Kelly

    More than half of US adults have hypertension by 40 years of age and a subsequent increase in atherosclerotic cardiovascular disease risk. Dietary sodium and potassium are intricately linked to the pathophysiology of hypertension. However, blood pressure responses to dietary sodium and potassium, phenomena known as salt and potassium sensitivity of blood pressure, respectively, are heterogenous and normally distributed in the general population. Like blood pressure, salt and potassium sensitivity are complex phenotypes, and previous research has shown that up to 75% of individuals experience a blood pressure change in response to such dietary minerals. Previous research has also implicated both high salt sensitivity and low salt sensitivity (or salt resistance) of blood pressure to an increased risk of hypertension and potentially atherosclerotic cardiovascular disease risk. Given the clinical challenges required to accurately measure the sodium and potassium response phenotypes, genomic characterization of these traits has become of interest for hypertension prevention initiatives on both the individual and population levels. Here, we review advances in human genomics research of blood pressure responses to dietary sodium and potassium by focusing on 3 main areas, including the phenotypic characterization of salt sensitivity and resistance, clinical challenges in diagnosing such phenotypes, and the genomic mechanisms that may help to explain salt and potassium sensitivity and resistance. Through this process, we hope to further underline the value of leveraging genomics and broader multiomics for characterizing the blood pressure response to sodium and potassium to improve precision in lifestyle approaches for primordial and primary atherosclerotic cardiovascular disease prevention.


  • Open Access

    Early Contributors to Healthy Arterial Aging Versus Premature Atherosclerosis in Young Adults: The Bogalusa Heart Study

    by Alexander C. Razavi, Lydia A. Bazzano, Jiang He, Marie Krousel‐Wood, Jing Chen, Camilo Fernandez, Seamus P. Whelton, Tanika N. Kelly

    Background: Early identification of healthy arterial aging versus premature atherosclerosis is important for optimal atherosclerotic cardiovascular disease risk stratification and prevention. We sought to identify predictors for the long‐term absence of carotid plaque among young adults. Methods and Results: We included 508 participants from the Bogalusa Heart Study without clinical atherosclerotic cardiovascular disease who were free of carotid plaque at baseline (2001–2002) and underwent ultrasound imaging at follow‐up (2013–2016). Modified Poisson regression estimated the persistent absence of plaque over 12.8 years. Participants were on average age 36.2 years at baseline, 64% were women, and 29% were Black. Although nearly all participants (97%) had a 10‐year atherosclerotic cardiovascular disease risk <7.5%, there were 162 people (32%) who developed premature atherosclerosis. Aside from younger age (risk ratio [RR], 1.21; 95% CI, 1.07–1.36, per 10 years) and a total cholesterol/high‐density lipoprotein cholesterol ratio <3.5 (RR, 1.15; 95% CI, 1.01–1.30), normal values of traditional risk factors did not predict long‐term absence of plaque. Independent from traditional markers including glomerular filtration rate, serum calcium‐phosphate product (RR, 1.07; 95% CI, 1.01–1.14, per 1‐SD lower), phosphate (RR, 1.15; 95% CI, 1.03–1.29, per 1 mg/dL lower), and dietary sodium <2300 mg/day (RR, 1.20; 95% CI, 1.02–1.41) were significantly associated with the non‐development of plaque. Conclusions: Nearly one third of young adults with a low burden of traditional risk factors developed premature atherosclerosis. Beyond younger age and an ideal lipoprotein profile, lower calcium‐phosphate homeostasis and low sodium intake were associated with long‐term absence of carotid plaque. These results suggest that dietary and intrinsic minerals are early contributors to the development of arterial aging phenotypes.


  • Open Access

    Discordantly normal ApoB relative to elevated LDL-C in persons with metabolic disorders: A marker of atherogenic heterogeneity

    by Alexander C. Razavi, Lydia A. Bazzano, Jiang He, Marie Krousel-Wood, Kirsten S. Dorans, Michael A. Razavi, Camilo Fernandez, Seamus P. Whelton, Tanika N. Kelly